COMPARATIVE ANALYSIS OF CARDIOMETABOLIC PARAMETERS IN PATIENTS WITH CORONARY ARTERY DISEASE WITH AND WITHOUT NAFLD

Article Sidebar

PDF (Русский)
Issue: Vol. 5 No. 3 : Eurasian Journal of Medical and Natural Sciences
Section: Articles
Published:
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Main Article Content

3rd year master student in Cardiology, Tashkent Medical Academy, Tashkent, 100109, Uzbekistan.
info@in-academy.uz
PhD, Deputy Director for Medical Work, Republican Specialized Scientific and Practical Medical Center of Cardiology, Tashkent, 100052, Uzbekistan.
info@in-academy.uz
PhD, Associate Professor of the Department of Internal Diseases No. 1 with the basics of preventive Medicine, Tashkent Medical Academy, Tashkent, 100109, Uzbekistan
info@in-academy.uz

Abstract:

Coronary heart disease (CHD) has been the leading cause of death worldwide for several decades. Non-alcoholic fatty liver disease (NAFLD), the most common liver pathology, is considered a risk factor (RF) for the development of coronary heart disease and a predictor of an unfavourable prognosis. Our study aims to compare cardiometabolic parameters in patients with CHD with and without NAFLD. The study prospectively included 85 patients with CHD, 61 with NAFLD (group I) and 24 without NAFLD (group II). In both groups, a comparative analysis of RF, anthropometric parameters, lipidogram, glycemic profile, and heart structural and geometric parameters according to echocardiography (EchoCG) and coronary calcium parameters was performed. It was found that patients with CHD and NAFLD had statistically significantly higher levels of total cholesterol, very low-density lipoproteins, triglycerides, insulin, structural parameters of the heart and coronary calcium. Thus, the relationship between NAFLD and CHD is two-way, and liver diseases can exacerbate the course of cardiovascular diseases.

Keywords:

Article Details

How to Cite:

Yusupalieva . Д., Nizamov У., & Shukurjanova С. (2025). COMPARATIVE ANALYSIS OF CARDIOMETABOLIC PARAMETERS IN PATIENTS WITH CORONARY ARTERY DISEASE WITH AND WITHOUT NAFLD. Eurasian Journal of Medical and Natural Sciences, 5(3), 228–235. Retrieved from https://in-academy.uz/index.php/EJMNS/article/view/47350

References:

Eriksen C. U., Rotar O., Toft U., Jorgensen T. What is the effectiveness of systematic population –level screening programmes for reducing the burden of cardiovascular diseases? – Copenhagen: WHO Regional Office for Europe. – 2021. – 107 p.

Шляхто Е. В., Звартау Н. Э., Виллевальде С. В., соавт. Система управления сердечно­сосудистыми рисками: предпосылки к созданию, принципы организации, таргетные группы // Российский кардиологический журнал. − 2019. − №11. − С. 69­82, doi.org/10.15829/1560-4071-2019-11-69-82.

Than N. N., Newsome P. N. A concise review of non-alcoholic fatty liver disease // Atherosclerosis. – 2015. – V.239. –P. 192-202.

Arslan U, Yenerçağ M. Relationship between non-alcoholic fatty liver disease and coronary heart disease // World J Clin Cases. – 2020. - 8(20). – P. 4688-4699.

Henson JB, Simon TG, Kaplan A, et al. Advanced fibrosis is associated with incident cardiovascular disease in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2020 Apr;51(7):728-736. doi: 10.1111/apt.15660.

Trovato F. M., Martines G. F., Catalano D., et al. Echocardiography and NAFLD (non-alcoholic fatty liver disease) // Int J Cardiol. – 2016. – №221. – Р. 275–284.

Fracanzani A. L., Pisano G., Consonni D., etal. Epicardial Adipose Tissue (EAT) Thickness Is Associated with Cardiovascular and Liver Damage in Nonalcoholic Fatty Liver Disease // PLoS ONE. – 2016. – Vol. 11 (9). –Р. 16-24, doi:10.1371/journal.pone.0162473.

Stahl E. P., Dhindsa D. S., Lee S. K., et al. Non-alcoholic Fatty Liver Disease and the Heart // Journal of the American College of Cardiology. – 2019. – №73 (8). – Р. 948-963, doi:10.1016/j.jacc.2018.11.050.